Effects of Activity on Diabetes Risk Among Breast Cancer Survivors on Endocrine Therapy (ABIDE)
Completed
Conditions studied: Breast Cancer
In brief
The aim of this study is to learn more about how physical activity and cardiorespiratory fitness are related to diabetes risk among breast cancer patients prescribed an endocrine therapy.
Key facts
- Study ID
- NCT06830486
- Run by
- University of Colorado, Denver
- People needed
- 40
- Starts
- 2022-02-14
- Expected to finish
- 2023-10-31
- Last updated by the study team
- 2026-02-05
Who can join
Age: 18 and older, up to 80. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Female
- diagnosed with breast cancer
- age 18-80 years
- Completed surgery, chemo- and/or radiation therapy
- Prescribed aromatase inhibitor or SERM for at least one year from the time of screening
You may not qualify if…
- Age < 18 or > 80
- Type 1 diabetes
- Type 2 diabetes
- Prescribed anti-hyperglycemic medication, insulin, or sulfonylurea.
- Pregnant, breastfeeding or planning to become pregnant in next 2 months
- Have absolute contraindications to exercise testing which are:
- Unstable angina
- Recent myocardial infarction, cardiac surgery, or vascular surgery (<3 months)
- Uncontrolled high blood pressure
- Heart failure
- Peripheral artery disease (based on report of symptomatic claudication)
- Hepatic or renal disease
- Severe arthritis or mobility impairment that would interfere with exercise testing
- Suspected cognitive impairment that would prevent understanding or comprehension of study procedures.
Where it is running
- University Of Colorado Anschutz Medical Campus — Aurora, Colorado, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.